More safety checks on new surgical techniques
By Jeremy Laurance, Health Editor
19 February 2003
Surgeons who try out new operations without authorisation are for the
first time to be subject to safety checks to prevent patients being used
unknowingly as guinea pigs.
The National Institute for Clinical Excellence, which assesses new drugs
and medical devices, is to extend its remit to checking the safety of all
new procedures involving making a cut or hole in the body and the use of
X-rays, lasers or ultrasound.
The aim is to prevent patients being used unwittingly for experimental
procedures that have not been assessed. Under the new programme, any surgeon
wishing to try a new procedure will first have to notify Nice and follow any
guidance available or gather data so that guidance can be produced. Patients
will also have to be informed about the risks and benefits of the proposed
treatment and that it is untested.
The move follows the débâcle over key-hole surgery, introduced in the
early 1990s, which was widely taken up by surgeons before the risks and
benefits had been assessed. The new technique called for different skills
from conventional surgery and patients were injured, some seriously.
A register was set up by the royal medical colleges in 1996 with the aim
of banning unsafe procedures and limiting unproven ones, but it fell into
abeyance because of lack of funding. Reacting to a recommendation in the
Bristol Royal Infirmary inquiry report, Nice is to take over its programme
and will issue its first guidance next month.
Among the first procedures likely to be covered are uterine artery
embolisation, a treatment for fibroids in the womb that offers an
alternative to hysterectomy and is growing rapidly in popularity, an
operation to correct a chest deformity in children and a less invasive
treatment for abnormal menstrual bleeding in women.
Later advice will cover laser treatment of the eye, widely provided by
commercial clinics for the treatment of short sight. They were criticised by
the Consumers' Association last week for underplaying the risks.
Professor Sir Liam Donaldson, the Government's chief medical officer,
said the absence of a mechanism for protecting patient safety when new
techniques were being tried was a "gap that needed to be closed".
Inno-vations that could bring medical advances of huge benefit must not be
stifled, Sir Liam added.
Sir Peter Morris, president of the Royal College of Surgeons, said the
real test would be whether the new programme curbed innovation. He welcomed
the plan to subject new procedures to rapid assessment.
Referring to an operation on the carotid artery in the neck developed in
the 1950s to reduce the risk of stroke, but not assessed in trials until the
1980s, he said: "We had to wait 30 years before we really knew if it was the
sort of thing we should be doing."
Five new procedures are expected to be notified to Nice each month.
Professor Bruce Campbell, chairman of the Interventional Procedures
Committee, said: "We all know very few procedures are completely safe. The
question is whether they are safe enough and work well enough to be used.
The fundamental aim is to reassure patients and their carers that they are
providing benefit without undue risk."
|